Pearls of Wisdom
In the Venture Capital industry, oncology is king
Last month, we discussed how venture capital investments in the life sciences industry remained strong in 2016 despite a dip in some areas versus 2015. A new analysis by EP Vantage looks at which therapy areas are winning the most investments by VC companies. The...
Join us for a Kelley School Life Sciences event on February 17
Indiana University’s Kelley School Center for the Business of Life Sciences is hosting a conference titled 2016 Election Effects on Life Sciences and Healthcare. Overview: Now that the winner of the presidential election and composition of the House and Senate has...
Save the date: IMDMC Medical Device event at the Indiana Statehouse February 15, 2017
On February 15, 2017, the Indiana Medical Device Manufacturers Council (IMDMC) will host the annual Medical Device Exhibit and Breakfast at the Indiana Statehouse. This event provides the opportunity to interact with state and federal officials about the industry. To...
NCI launches new drug formulary to speed up clinical trials
Last week, the National Cancer Institute (NCI) launched a new drug formulary. The NCI Formulary will “enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents to use in preclinical studies and cancer clinical...
CDER’s novel drug approvals for 2016: a review
Last week, John Jenkins, M.D. issued a review of the FDA’s new drugs program in the Center for Drug Evaluation and Research (CDER). The total number of new drug approvals decreased dramatically in 2016 versus the previous year; however, Jenkins, who is the Director of...